Genetic aspects of the development of overweight
DOI:
https://doi.org/10.32402/dovkil2025.01.011Keywords:
metabolic syndrome, obesity, leptin, gene, receptor, healthAbstract
Numerous clinical studies have established that excess weight has a significant impact on the entire state of the body, regardless of age and gender. Metabolic syndrome is a heterogeneous pathological condition that combines different stages of obesity, which is a key element of this syndrome. Hormonal disorders, the central ones being insulin resistance and leptin resistance, trigger a cascade of neuroendocrine changes that lead to the progression of the metabolic syndrome. Purpose: to analyse the development of overweight from the point of view of genetic aspects. Materials and methods: We examined 375 adult patients aged 20 to 70 years old, of whom 20.3% were men and 79.7% were women, who were exposed to a modifiable factor – overweight or obesity, which is a trigger for the prevalence of leptin resistance. In the course of the study, anthropometric parameters (waist circumference, height, weight, body mass index), laboratory parameters (leptin, glucose, insulin, Homa index), information and analytical analysis of the latest studies of gene regulation of overweight in humans were determined, and statistical data processing was performed using the STATISTICA v.8.0 software package. The results: 375 patients with an average age of (46.8±0.7) years old participated in the study. Male and female groups did not statistically differ in age (t=0.3; p=0.745). In male patients, height (t=12.2; p<0.001), weight (t=8.2; p<0.001) and waist circumference (t=3.4; p<0.001) were higher by 6.4%, respectively, 19.1% and 10.5% than in women. The average value of BMI for the entire sample was (30.0±0.3) kg/m2. Among female patients, the highest BMI was determined in the group of 60-79 years old, and the lowest in the group of 30-49 years old. The research established that (81.4±2.0)% of the examined were overweight or of various degrees of obesity. Conclusions: An in depth comprehensive examination of patients made it possible to assess the health characteristics of overweight or obese patients aged 20 to 70 years old and to create a patient registry, which will contribute to the improvement of diagnostics and stratification of the degree of risk of pathological changes. Analysis of the literature showed that the development of obesity in humans is facilitated by functional mutations that affect the components of the leptin pathway and block the work of the leptin gene or its receptor gene.Downloads
References
1. World Health Organization (WHO). Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
2. Babenko V, Babenko R, Gamieldien J, Markel A. FTO haplotyping underlines high obesity risk for European populations. BMC Medical Genomics. 2019 Mar ;12(S2). https://doi.org/10.1186/s12920-019-0491-x
3. Stenberg K, Novotny GW, Lutz TA, Mandrup–Poulsen T, Bjшrnvad CR. Obesity–induced changes in gene expression in feline adipose and skeletal muscle tissue. Journal of Animal Physiology and Animal Nutrition. 2023 Jan 2. https://doi.org/10.1111/jpn.13802
4. Barone I, Giordano C. Leptin and beyond: actors in cancer. Biomolecules . 2021 Dec 6 ;11(12):1836. https://doi.org/10.3390/biom11121836
5. D’souza AM, Neumann UH, Glavas MM, Kieffer TJ. The glucoregulatory actions of leptin. Molecular Metabolism. 2017 Sep; 6(9):1052-65. https://doi.org/10.1016/j.molmet.2017.04.011
6. Zhang Y, Chua S J. Leptin function and regulation. Comprehensive Physiology. 2017; 8(1):351-69. https://doi.org/10.1002/j.2040-4603.2018.tb00002.x
7. Liu RB, Liu Y, Lv LQ, Xiao W, Gong C, Yue JX. Effects of metformin treatment on soluble leptin receptor levels in women with polycystic ovary syndrome. Current Medical Science. 2019 Jul 25; 39(4):609-14. https://doi.org/10.1007/s11596-019-2081-8
8. Mahmoud R, Kimonis V, Butler MG. Genetics of obesity in humans: a clinical review. International Journal of Molecular Sciences. 2022 Sep 20; 23(19):11005. https://doi.org/10.3390/ijms231911005
9. Saxton RA, Caveney NA, Moya-Garzon MD, Householder KD, Rodriguez GE, Burdsall KA et al. Structural insights into the mechanism of leptin receptor activation. Nature Communications. 2023 Mar 31; 14(1). https://doi.org/10.1038/s41467-023-37169-6
10. Gao X, Murphy MM, Peyer JG, Ni Y, Yang M, Zhang Y et al. Leptin receptor+ cells promote bone marrow innervation and regeneration by synthesizing nerve growth factor. Nature Cell Biology. 2023 Nov 27. https://doi.org/10.1038/s41556-023-01284-9
11. Lуpez-Hidalgo M, Caro-Gуmez LA, Romo-Rodrнguez R, Herrera-Zuсiga LD, Anaya-Reyes M, Rosas-Trigueros JL et al. Atomistic mechanism of leptin and leptin-receptor association. Journal of Biomolecular Structure and Dynamics. 2022 Jan 25 : 1-18. https://doi.org/10.1080/07391102.2022.2029568
12. Bouafi H, Krami AM, Morjane I, Slaoui K, Harmak H, Charoute H et al. Genetic association of LEP gene polymorphisms with obesity in moroccan individuals: case-control study and updated meta-analysis. Biochemical Genetics. 2023 Feb 15. https://doi.org/10.1007/s10528-023-10342-8
13. Wasim M, Awan FR, Najam SS, Khan AR, Khan HN. Role of leptin deficiency, inefficiency, and leptin receptors in obesity. Biochemical Genetics. 2016 Jun 16; 54(5):565-72. https://doi.org/10.1007/s10528-016-9751-z
14. Saeed S, Bonnefond A, Manzoor J, Shabir F, Ayesha H, Philippe J et al. Genetic variants in LEP, LEPR and MC4R explain 30% of severe obesity in children from a consanguineous population. Obesity. 2015 Jul 14; 23(8):1687-95. https://doi.org/10.1002/oby.21142
15. Kleinendorst L, Abawi O, van der Kamp HJ, Alders M, Meijers-Heijboer HE, van Rossum EF, van den Akker EL et al. Leptin receptor deficiency: a systematic literature review and prevalence estimation based on population genetics. European Journal of Endocrinology. 2020 Jan; 182(1):47-56. https://doi.org/10.1530/eje-19-0678
16. Chaves C, Kay T, Anselmo J. Early onset obesity due to a mutation in the human leptin receptor gene. Endocrinology, Diabetes & Metabolism Case Reports . 2022 Aug 1 ;2022. https://doi.org/10.1530/edm-21-0124
17. Huvenne H, Le Beyec J, Pйpin D, Alili R, Kherchiche PP, Jeannic E et al. Seven novel deleterious LEPR mutations found in early-onset obesity: a дexon 6-8 shared by subjects from reunion island, france, suggests a founder effect. The Journal of Clinical Endocrinology & Metabolism. 2015 May 1; 100(5):E757-E766. https://doi.org/10.1210/jc.2015-1036
18. Helgeland Ш, Vaudel M, Juliusson PB, Lingaas Holmen O, Juodakis J, Bacelis J et al. Genome-wide association study reveals dynamic role of genetic variation in infant and early childhood growth. Nature Communications. 2019 Oct 1; 10(1). https://doi.org/10.1038/s41467-019-12308-0
19. Prodan AM. Predicting the probability of developing obesity depending on leptin and leptin receptor polymorphisms. Medical and Clinical Chemistry. 2024 Apr 29; (1):46-53. https://doi.org/10.11603/mcch.2410-681x.2024.i1.14597
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Environment & Health
This work is licensed under a Creative Commons Attribution 4.0 International License.
